Allergy Testing Access Act of 2019

United States116th CongressS-2246Senate
Updated: Jul 24, 2019

Summary

Allergy Testing Access Act of 2019 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Bill texts

Available versions
Introduced (Senate)View official text

1 version available

All available records shown.

Timeline

  1. Read twice and referred to the Committee on Finance.

    Senate

  2. Introduced in Senate

All available records shown.